Subscribe

H&R GmbH & Co. KGaA (2HRA.DE)

EUR6.12 -0.04 (-0.65%)
DE XETRA Basic Materials Chemicals - Specialty
Address Neuenkirchener Strasse 8 48499
Salzbergen, DE
CEO Niels H. Hansen
Website hur.com
IPO 2000-01-17
ISIN DE000A2E4T77

Explore sections of this company profile

Also trades on Deutsche Börse · 2HRA.DE (EUR) London Stock Exchange · 0RRC.L (EUR)
Description

H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
EUR6.12 -0.04 (-0.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
4.0K
Beta
0.36
Float Shares
10.86M
Free Float %
29.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.84% +3.49% +19.35% +7.71% -3.85% +10.98% +15.57% -10.04% -31.16% -55.36% +23.70%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
6.12
DCF (Unlevered) 13.33 +117.8%
DCF (Levered) 7.29 +19.1%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 33% Bullish
Rating 2026-05 Change
Strong Buy 1 +1
Buy 0 0
Hold 0 0
Sell 1 0
Strong Sell 1 0
Quality scores
Altman Z-Score
2.00
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    -7.2% Q1'26: -13.2% (vs Q1'25)
  • ✗
    EPS growth Chemicals - Specialty: +13.2%
    -458.6% Q1'26: +100.0% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +0.8% Q1'26: +9.1% (vs Q1'25)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +1.0% Q1'26: +3.2% (vs Q1'25)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +2.3% Q1'26: +4.3% (vs Q1'25)
  • ✓
    Share dilution Chemicals - Specialty: +0.1%
    +0.0% Q1'26: +3.0% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    2.65× Q1'26: 4.82× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.35) × ERP
WACC = 49% × Ke + 51% × Kd (5.0%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 13.33 Current price: 6.12
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2011
actual 		Dec 2012
actual 		Dec 2013
actual 		Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
2 Rev. Ana.
1 EPS Ana. 		Dec 2027
2 Rev. Ana.
2 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana. 		Dec 2029
1 Rev. Ana.
1 EPS Ana. 		Dec 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
1.21B
est: 1.20B (+1.0%)
1.23B
est: 1.26B (-2.7%)
1.21B
est: 1.25B (-3.1%)
1.06B
est: 1.12B (-5.7%)
982.91M
est: 1.05B (-6.0%)
942.65M
est: 936.55M (+0.7%)
1.03B
est: 1.03B (+0.0%)
1.11B
est: 1.09B (+1.8%)
1.08B
est: 1.07B (+0.3%)
873.03M
est: 899.70M (-3.0%)
1.19B
est: 1.16B (+2.2%)
1.58B
est: 1.57B (+0.1%)
1.35B
est: 1.34B (+0.9%)
1.34B
est: 1.27B (+5.3%)
1.24B
est: 1.27B (-2.1%)
1.32B
1.28B – 1.35B
+3.8% YoY
1.35B
1.31B – 1.39B
+2.6% YoY
1.38B
1.37B – 1.40B
+2.3% YoY
1.47B
1.42B – 1.51B
+6.0% YoY
1.51B
1.46B – 1.55B
+2.7% YoY
EBITDA
88.52M
est: 101.30M (-12.6%)
45.23M
est: 70.26M (-35.6%)
31.65M
est: 4.63M (+582.9%)
30.51M
est: 9.08M (+236.0%)
79.86M
est: 6.28M (+1,172.5%)
100.39M
est: 52.42M (+91.5%)
90.19M
est: 87.26M (+3.4%)
74.06M
est: 94.45M (-21.6%)
52.64M
est: 63.53M (-17.1%)
48.42M
est: 32.40M (+49.4%)
131.35M
est: 33.47M (+292.4%)
123.76M
est: 34.51M (+258.6%)
88.33M
est: 101.44M (-12.9%)
91.69M
est: 96.24M (-4.7%)
69.19M
est: 96.05M (-28.0%)
99.75M
96.93M – 102.56M
+3.8% YoY
102.38M
99.19M – 105.57M
+2.6% YoY
104.75M
103.54M – 105.97M
+2.3% YoY
111.08M
107.78M – 114.38M
+6.0% YoY
114.03M
110.64M – 117.42M
+2.7% YoY
EBIT
67.50M
est: 92.40M (-26.9%)
21.36M
est: 71.94M (-70.3%)
5.29M
est: 24.91M (-78.8%)
4.87M
est: -4.03M (+220.7%)
47.07M
est: 5.41M (+770.7%)
66.50M
est: 43.18M (+54.0%)
55.69M
est: 67.48M (-17.5%)
42.15M
est: 59.49M (-29.1%)
7.23M
est: 40.56M (-82.2%)
-2.59M
est: 5.91M (-143.7%)
80.41M
est: 6.11M (+1,216.4%)
69.61M
est: 6.30M (+1,005.4%)
29.87M
est: 44.89M (-33.5%)
32.19M
est: 42.59M (-24.4%)
11.88M
est: 42.50M (-72.0%)
44.14M
42.89M – 45.39M
+3.8% YoY
45.31M
43.90M – 46.72M
+2.6% YoY
46.36M
45.82M – 46.89M
+2.3% YoY
49.15M
47.69M – 50.62M
+6.0% YoY
50.46M
48.96M – 51.96M
+2.7% YoY
Net Income
38.48M
est: 58.81M (-34.6%)
457.0K
est: 40.85M (-98.9%)
-14.03M
est: 396.9K (-3,634.4%)
-15.40M
est: -12.55M (-22.8%)
26.90M
est: -14.59M (+284.3%)
38.37M
est: 24.03M (+59.7%)
32.13M
est: 40.68M (-21.0%)
21.59M
est: 35.21M (-38.7%)
-1.37M
est: 21.80M (-106.3%)
-9.02M
est: -1.17M (-671.2%)
50.18M
est: -1.21M (+4,252.7%)
42.71M
est: 16.72M (+155.4%)
10.56M
est: 9.57M (+10.3%)
10.62M
est: 13.68M (-22.4%)
-38.80M
est: 2.61M (-1,589.1%)
8.34M
8.02M – 8.66M
+220.1% YoY
11.30M
5.95M – 14.17M
+35.5% YoY
12.07M
11.60M – 12.54M
+6.8% YoY
16.81M
16.16M – 17.46M
+39.2% YoY
17.24M
16.57M – 17.91M
+2.6% YoY
SGA
—
est: 156.52M (-100.0%)
32.12M
est: 148.34M (-78.3%)
29.41M
est: 75.32M (-60.9%)
26.72M
est: 120.80M (-77.9%)
32.57M
est: 130.33M (-75.0%)
34.86M
est: 159.93M (-78.2%)
33.68M
est: 203.92M (-83.5%)
34.89M
est: 211.03M (-83.5%)
36.92M
est: 196.71M (-81.2%)
34.35M
est: 159.28M (-78.4%)
43.62M
est: 164.55M (-73.5%)
54.37M
est: 169.64M (-68.0%)
47.86M
est: 37.88M (+26.4%)
46.55M
est: 35.94M (+29.5%)
—
est: 35.87M (-100.0%)
37.25M
36.20M – 38.30M
+3.8% YoY
38.23M
37.04M – 39.42M
+2.6% YoY
39.12M
38.67M – 39.57M
+2.3% YoY
41.48M
40.25M – 42.71M
+6.0% YoY
42.58M
41.32M – 43.85M
+2.7% YoY
EPS
1.26
est: 1.39 (-9.1%)
0.02
est: 0.32 (-93.9%)
-0.46
est: -0.26 (-75.6%)
-0.48
est: -0.10 (-380.0%)
0.74
est: 0.67 (+10.2%)
1.05
est: 1.08 (-2.6%)
0.88
est: 0.87 (+0.7%)
0.59
est: 0.60 (-0.8%)
-0.04
est: 0.04 (-214.3%)
-0.24
est: 0.12 (-300.0%)
1.35
est: 1.30 (+3.8%)
1.15
est: 1.01 (+13.9%)
0.28
est: 0.26 (+8.9%)
0.29
est: 0.37 (-21.1%)
-1.04
est: 0.07 (-1,585.7%)
0.22
0.22 – 0.23
+220.1% YoY
0.27
0.16 – 0.38
+20.7% YoY
0.32
0.31 – 0.34
+20.0% YoY
0.45
0.43 – 0.47
+39.2% YoY
0.46
0.45 – 0.48
+2.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C 2/5 5/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-05-07 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-05-06 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-05-05 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-05-04 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-30 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-29 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-28 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-27 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-24 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-23 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-22 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-21 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-20 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-17 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5
2026-04-16 B- 2/5 5/5 1/5 1/5 1/5 1/5 5/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-9.16M
OE per share TTM
-0.26
Owner's Yield
-4.95%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
35.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
7.0K
Shares Outstanding
37.22M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Niels H. Hansen CEO & Chairman of the Executive Board 716.7K male
Ties Kaiser Head of Investor Relations & Communication — —
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty